Delivery Order SPE2DB20D3303-SPE2DB24FA1QY
Award Date
7/31/24
Potential Completion Date
8/21/24
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 200-unit vials of BOTOX to the Defense Logistics Agency (DLA), a defense agency. The $10,257.48 firm-fixed-price delivery order contract was awarded on June 17, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of July 10, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,643.70 firm fixed-price delivery order is for 4,567,178,994 units of BOTOX 200 unit vials. The contract has an ultimate completion date of February 27, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle...
This federal contract award is for the delivery of 200-unit vials of BOTOX to the Defense Logistics Agency (DLA), a defense agency. The $1,709.60 firm fixed-price delivery order contract has a completion date of July 22, 2025 and was awarded on June 30, 2025 to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is not set aside and allows for the supply of a range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation that serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies. The award is a firm fixed price delivery order for 4,563,856,643 units of BOTOX 200 with a potential value of $3,492.78 and a performance period through March 22, 2024. This award is not associated with any set-aside...
This federal contract award is for the delivery of 200-unit vials of BOTOX to the Defense Logistics Agency (DLA). The $13,971.12 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a completion date of January 30, 2024 and was awarded on January 8, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp has a history of providing pharmaceuticals,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,564.37 firm fixed-price delivery order is for the supply of 200-unit vials of BOTOX. The contract has an ultimate completion date of July 9, 2025 and was awarded on June 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award is for the delivery of 100-unit vials of BOTOX to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a Firm Fixed Price of $1,722.72. The contract has an ultimate completion date of July 2, 2025 and was awarded on June 10, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BOTOX 200 unit vials to the U.S. government. The $4,657.04 firm-fixed price contract was awarded on June 26, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). This is a delivery order under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $13,971.12 firm fixed price delivery order is for the provision of 200-unit vials of Botox. The contract has no set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00...
This federal contract award is for the delivery of BOTOX 200 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $13,971.12 and a completion date of May 23, 2024. The place of performance is Conshohocken, PA. This...